{"id":"W3021210585","doi":"10.1002/cam4.3116","title":"Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab","year":2020,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Regorafenib; Cabozantinib; Sorafenib; Ramucirumab; Medicine; Hepatocellular carcinoma; Internal medicine; Oncology; Liver function; Gastroenterology; Overall survival; Renal cell carcinoma; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000189245,0.0003752902,0.000894655,0.0001077576,0.0001032038,0.00001557628,0.00007532471,0.00008663745,0.0006507649],"category_scores_gemma":[0.0000380981,0.0002353406,0.00015222,0.0003032395,0.000336059,0.00009487299,0.00003935963,0.00008519347,0.000003265397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001224585,"about_ca_system_score_gemma":0.00009997648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005613812,"about_ca_topic_score_gemma":0.0001355387,"domain_scores_codex":[0.9981019,0.00007408693,0.000547888,0.000628742,0.0002687813,0.0003786277],"domain_scores_gemma":[0.9986941,0.0001886625,0.0002028968,0.0004131116,0.0001185799,0.0003826281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002105354,0.0001661807,0.9595643,0.0002474624,0.0003115155,0.0001258945,0.003439051,6.4387e-8,0.02405731,0.00002773843,0.0001202121,0.009834867],"study_design_scores_gemma":[0.01607278,0.003383138,0.9423981,0.0001363469,0.001253789,0.00001990066,0.0002328252,0.001631103,0.02038364,0.00002560746,0.01422862,0.0002341362],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871169,0.004982919,0.00002241313,0.005503965,0.00007915251,0.002021577,0.0001214389,0.00005112844,0.000100534],"genre_scores_gemma":[0.9963894,0.0009834344,0.000136723,0.0006797752,0.0005050965,0.0006376529,0.0001297608,0.00005093162,0.0004872612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01716623,"threshold_uncertainty_score":0.9596912,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08587474103254476,"score_gpt":0.3101469255419624,"score_spread":0.2242721845094176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}